134 related articles for article (PubMed ID: 36411174)
21. Occult contralateral central neck metastasis in papillary thyroid carcinoma with preoperatively documented ipsilateral lateral neck metastasis.
Back K; Choe JH; Kim JS; Kim JH
Eur J Surg Oncol; 2021 Jun; 47(6):1339-1345. PubMed ID: 33744024
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
23. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
24. Partial Thyroidectomy With Incidental Metastatic Lymph Nodes.
Alameer E; Eagan A; Scholfield DW; Woods RSR; Tuttle RM; Wong RJ; Patel SG; Ganly I
JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):49-56. PubMed ID: 37971746
[TBL] [Abstract][Full Text] [Related]
25. Ipsilateral Central Neck Dissection Plus Frozen Section Examination Versus Prophylactic Bilateral Central Neck Dissection in cN0 Papillary Thyroid Carcinoma.
Raffaelli M; De Crea C; Sessa L; Fadda G; Bellantone C; Lombardi CP
Ann Surg Oncol; 2015 Jul; 22(7):2302-8. PubMed ID: 25652046
[TBL] [Abstract][Full Text] [Related]
26. Incidence and clinical characteristics of prelaryngeal lymph node metastasis in papillary thyroid cancer.
Lee YC; Shin SY; Kwon KH; Eun YG
Eur Arch Otorhinolaryngol; 2013 Sep; 270(9):2547-50. PubMed ID: 23553243
[TBL] [Abstract][Full Text] [Related]
27. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.
Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J
Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035
[TBL] [Abstract][Full Text] [Related]
28. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection.
Yoo HS; Shin MC; Ji YB; Song CM; Lee SH; Tae K
Asian J Surg; 2018 Jul; 41(4):363-369. PubMed ID: 28454667
[TBL] [Abstract][Full Text] [Related]
29. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma.
Hartl DM; Mamelle E; Borget I; Leboulleux S; Mirghani H; Schlumberger M
World J Surg; 2013 Aug; 37(8):1951-8. PubMed ID: 23677562
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
Gambardella C; Tartaglia E; Nunziata A; Izzo G; Siciliano G; Cavallo F; Mauriello C; Napolitano S; Thomas G; Testa D; Rossetti G; Sanguinetti A; Avenia N; Conzo G
World J Surg Oncol; 2016 Sep; 14(1):247. PubMed ID: 27644091
[TBL] [Abstract][Full Text] [Related]
31. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma.
Hartl DM; Leboulleux S; Al Ghuzlan A; Baudin E; Chami L; Schlumberger M; Travagli JP
Ann Surg; 2012 Apr; 255(4):777-83. PubMed ID: 22418010
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V
Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of the patterns of cervical lymph node recurrence in patients with cN0 papillary thyroid carcinoma after central neck lymph node dissection].
Huang H; Xu Z; Wang X; Wu Y; Liu S
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):771-5. PubMed ID: 26813598
[TBL] [Abstract][Full Text] [Related]
34. Total thyroidectomy with therapeutic level II-IV neck dissection for papillary thyroid carcinoma: level VI recurrence patterns.
Carmel-Neiderman NN; Duek I; Amsterdam D; Wengier A; Kuzmenko B; Ringel B; Warshavsky A; Shapira U; Horowitz G; Izkhakov E; Fliss DM
Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3449-3455. PubMed ID: 32488373
[TBL] [Abstract][Full Text] [Related]
35. Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.
Mamelle E; Borget I; Leboulleux S; Mirghani H; Suárez C; Pellitteri PK; Shaha AR; Hamoir M; Robbins KT; Khafif A; Rodrigo JP; Silver CE; Rinaldo A; Ferlito A; Hartl DM
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1577-86. PubMed ID: 25022716
[TBL] [Abstract][Full Text] [Related]
36. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
[TBL] [Abstract][Full Text] [Related]
37. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
38. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
[TBL] [Abstract][Full Text] [Related]
39. A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma.
Ahn JH; Kwak JH; Yoon SG; Yi JW; Yu HW; Kwon H; Kim SJ; Lee KE
Surgery; 2022 Jan; 171(1):182-189. PubMed ID: 34391573
[TBL] [Abstract][Full Text] [Related]
40. The prognostic factors for clinical N1b patients in thyroid papillary carcinoma.
Yuksel UM; Turanli S; Acar Y; Berberoglu U
J Cancer Res Ther; 2019; 15(3):681-685. PubMed ID: 31169240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
